Bioinformatic analysis revealed that the GJA1 expression was enhanced in HNSCC tumor tissues (Figures 6(a) and 6(b)), and Kaplan–Meier survival data demonstrated that the higher GJA1 expression presented a worse OS rate in HNSCC patients (Figure 6(c)). This evidence concerns the gene GJA1 and head and neck squamous cell carcinoma.